Clinical Trial Update: Characterization of Skin Immunity to Aedes Aegypti Saliva in Dengue-endemic Participants in Cambodia [Phase 1]

View source ↗

Summary

Phase 1 trial characterizing skin immune responses to Aedes aegypti saliva in dengue-endemic participants in Cambodia; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue
• Vector-borne Diseases

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Vector Borne Diseases | Phase 1 | Status: COMPLETED | Results posted: 2022-04-12